语言版本language

中文版 English 日本語 한국어

1990-2020 Enterprise Yearbook

Future

As the raw material business unit, Bloomage Biotech Bioactive will keep providing innovative solutions and technical support to our valued partners.

2021

In China, sodium hyaluronate declared by Bloomage Biotech was officially approved by the National Health Commission as a new food raw material for ordinary food.
Subsidiary company Bloomage Biotech (Tianjin) CO., LTD. established.
Biobloom Microecobeauty ME-2 launched!
Bloomage Biotech won the 8th Shandong Governor Quality Award.

2020

Subsidiary company Bloomage Biotechnology Japan CO., LTD. established.
Hyafactor - PGA-SHM lauched.

2019

Name changed to Bloomage Biotechnology Corporation Limited.

Hyafactor™-SG Sclerotium Gum Hydrogel launched.

2018

EFfCI GMP certified.

Feed Additive Production License cotained for feed grade HA.

More DMFs filed at China FDA.

Hymagic™-4D 4D Hyaluronic Acid & microHA™ Super Active Hyaluronic Acid launched.

Biomoist™ Hyaluronic Acid for Oral Care launched.

2017

Environmental Management System and Occupational Health and Safety Management System certified.

HACCP and ISO 22000 certified.

Indian registration for pharmaceutical grade HA obtained.

Hymagic™-AcHA Sodium Acetylated Hyaluronate obtained launched.

2016

Russian registration for pharmaceutical grade HA.

2015

Hyacross™ Hyaluronic Acid Elastomer launched.

Gabarelax™ Gamma Aminobutyric Acid obtained Food Production License and launched.

2014

Fermentation Platform was established.

Japan MF and Canada DMF registration.

Gabacare™ BL98T Aminobutyric Acid was launched.

2013

KDMF registered for pharmaceutical grade HA.

HA Technology Platform established.

2012

Passed US FDA on-site audit.

Subsidiary company established.

2011

China GMP approved.

CEP certifications and US DMFs obtained.

miniHA™ - the world first HA-Oligo by enzymatic degradation successfully launched.

2008

HAPLEX® approved as a New Dietary Ingredient in China.

2004

Pharmaceutical Excipient License obtained.

2001

Bloomage International Investment Group invested in the company.

ISO 9001 certified.

2000

Company Established

The project of producing hyaluronic acid by fermentation won the "excellent achievement award of national key Science and technology public relations Plan" in the ninth five-year Plan in China

1990

Chief Scientist Dr. Guo Xueping initiated the research on producing HA by bio-fermentation technology.

Past

Time to remember.

About Us
Products
News
Sustainability
Contact Us